Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Product Information
-
DIN:02390442
-
Active Ingredients :Clarithromycin
-
Innovator Name:Biaxin®
-
Category:Antibiotic
-
Dosage form:Oral Suspension (after powder reconstitution)
-
Strength:125 mg/5 mL
-
Route of Administration:Oral
-
Colour:white to off-white granular powder, forming white to off-white suspension on reconstitution with water
- Package size:
55 mL bottle (after reconstitution) 105 mL bottle (after reconstitution) - UPC Code:
063691085251 063691085282 -
Non-medicinal ingredients :Consist of a layering of clarithromycin on sucrose with hypromellose, hydroxylpropyl cellulose, povidone (K30) alginic acid and acetone, which is further coated with HP-55 polymer (hypromellose phthalate). Mixed with a blend of (sucrose, aspartame, xanthan gum, colloidal silicon dioxide, sodium citrate (dihydrate), citric acid (anhydrous), flavour peppermint, flavour tutti frutti, sodium benzoate, sodium chloride, castor oil, titanium dioxide, croscarmellose sodium and maltodextrin,)
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02390450
-
Active Ingredients :Clarithromycin
-
Innovator Name:Biaxin®
-
Category:Antibiotic
-
Dosage form:Oral Suspension (after powder reconstitution)
-
Strength:250 mg/5 mL
-
Route of Administration:Oral
-
Colour:white to off-white granular powder, forming white to off-white suspension on reconstitution with water
- Package size:
105 mL bottle (after reconstitution) - UPC Code:
063691085299 -
Non-medicinal ingredients :Consist of a layering of clarithromycin on sucrose with hypromellose, hydroxylpropyl cellulose, povidone (K30) alginic acid and acetone, which is further coated with HP-55 polymer (hypromellose phthalate). Mixed with a blend of (sucrose, aspartame, xanthan gum, colloidal silicon dioxide, sodium citrate (dihydrate), citric acid (anhydrous), flavour peppermint, flavour tutti frutti, sodium benzoate, sodium chloride, castor oil, titanium dioxide, croscarmellose sodium and maltodextrin,)
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here